Hanall Biopharma Co (XKRX:009420) Accounts Payable & Accrued Expense : ₩20,394 Mil (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Accounts Payable & Accrued Expense?

Hanall Biopharma Co's quarterly accounts payable & accrued expense declined from Jun. 2023 (₩16,338 Mil) to Sep. 2023 (₩12,299 Mil) but then increased from Sep. 2023 (₩12,299 Mil) to Dec. 2023 (₩20,394 Mil).

Hanall Biopharma Co's annual accounts payable & accrued expense increased from Dec. 2021 (₩8,253 Mil) to Dec. 2022 (₩14,162 Mil) and increased from Dec. 2022 (₩14,162 Mil) to Dec. 2023 (₩20,394 Mil).

Hanall Biopharma Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Hanall Biopharma Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Accounts Payable & Accrued Expense Chart

Hanall Biopharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

11,745.59

9,145.48

8,253.26

14,162.03

20,393.55

Hanall Biopharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															14,162.03	13,545.91	16,338.13	12,298.63	20,393.55

Hanall Biopharma Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Hanall Biopharma Co (XKRX:009420) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR

Website

http://www.hanall.co.kr

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines